SCHEMBL23557635

SCHEMBL23557635

Oc1ccc(-c2cn(-c3ccccc3C(F)(F)F)nn2)cc1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MIF P14174 4/20 0.54
▸ HSD17B1 P14061 2/20 0.51
▸ HSD17B2 P37059 2/20 0.51
▸ BCHE P06276 1/20 0.48
▸ TRPV1 Q8NER1 1/20 0.45
▸ ABCG2 Q9UNQ0 3/20 0.44
▸ STS P08842 1/20 0.44
▸ P2RY14 Q15391 1/20 0.44
▸ ABCB1 P08183 1/20 0.42
▸ ALOX5 P09917 1/20 0.42
▸ APP P05067 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ CA5A P35218 1/20 0.40
▸ CA5B Q9Y2D0 1/20 0.40
▸ LDHA P00338 1/20 0.39
▸ PTGS2 P35354 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28875210 0.88 BCHE (0.60) BCHETRPV1ABCG2STSABCB1
SCHEMBL23557663 0.83 HSD17B1 (0.48) MIFHSD17B1HSD17B2STSP2RY14
SCHEMBL23557568 0.80 MIF (0.51) MIFHSD17B1HSD17B2BCHEABCG2
SCHEMBL23557743 0.78 STS (0.73) BCHETRPV1ABCG2STSCA1
SCHEMBL18031113 0.78 ABCG2 (0.54) MIFBCHEABCG2P2RY14ABCB1
SCHEMBL25055359 0.76 MIF (0.74) MIFHSD17B1HSD17B2BCHEABCG2
SCHEMBL18031620 0.75 CA1 (0.67) MIFHSD17B1HSD17B2CA1CA2
SCHEMBL2262206 0.75 P2RY14 (0.52) MIFHSD17B1HSD17B2ABCG2P2RY14
SCHEMBL23557657 0.74 PTGS2 (0.66) MIFHSD17B1HSD17B2P2RY14CA1
SCHEMBL23086229 0.74 HSD17B1 (0.74) MIFHSD17B1HSD17B2ALOX5CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3790868-B1 SULFAMATE DERIVATIVES OF 4-(1-PHENYL-1H-[1,2,3]TRIAZOL-4-YL)-PHENOL, DERIVATIVES OF 4-(1-PHENYL-1H-[1,2,3]TRIAZOL-4-YL)-PHENOL, THEIR MEDICAL USE AND THE METHOD OF OBTAINING 4-(1-PHENYL-1H-[1,2,3]TRIAZOL-4-YL)-PHENYL SULFAMATE DERIVATIVES POLITECHNIKA GDANSKA (PL) 2023-01-11 — — EP disclosed
US-20210188785-A1 SULFAMATE DERIVATIVES OF 4-(1-PHENYL-1H-[1,2,3]TRIAZOL-4-YL)-PHENOL, DERIVATIVES OF 4-(1-PHENYL-1H-[1,2,3]TRIAZOL-4-YL)-PHENOL, THEIR MEDICAL USE AND THE METHOD OF OBTAINING 4-(1-PHENYL-1H-[1,2,3]TRIAZOL-4-YL)-PHENYL SULFAMATE DERIVATIVES POLITECHNIKA GDANSKA (PL) 2021-06-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210188785-A1 SULFAMATE DERIVATIVES OF 4-(1-PHENYL-1H-[1,2,3]TRIAZOL-4-YL)-PHENOL, DERIVATIVES OF 4-(1-PHENYL-1H-[1,2,3]TRIAZOL-4-YL)-PHENOL, THEIR MEDICAL USE AND THE METHOD OF OBTAINING 4-(1-PHENYL-1H-[1,2,3]TRIAZOL-4-YL)-PHENYL SULFAMATE DERIVATIVES SULT1E1, SULT2A1, SULT1A1 MIF 1115/4885HSD17B1 136/4885HSD17B2 221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback